SCHEMBL23918003

SCHEMBL23918003

CCCCN1C=CN(CCCC)C1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15724546 0.94
SCHEMBL2432495 0.75
SCHEMBL329331 0.73 GBA1 (0.32)
SCHEMBL5282947 0.71 TP53 (0.31)
SCHEMBL667070 0.71
SCHEMBL5278925 0.71
SCHEMBL5282358 0.70 TP53 (0.30)
SCHEMBL5296936 0.70 TP53 (0.30)
SCHEMBL5286518 0.70 EBP (0.36)
SCHEMBL5287172 0.70 GBA1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317153-A1 IRIDIUM (III) COMPLEXES CONTAINING N-HETEROCYCLIC CARBENE LIGAND, SYNTHESIS, AND THEIR USE THEREOF IN CANCER TREATMENT THE UNIVERSITY OF HONG KONG (HK) 2021-10-14 US disclosed